Top 50 Biotech Startup Investors in Japan (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Mitsubishi UFJ Capital
VC Fund
|
29 | Japan, United States, Singapore | Series A, Series B | Information Technology, Software, Health Care | $1.2M–$38M |
|
SMBC Venture Capital
VC Fund
|
26 | Japan, United States, Singapore | Series A, Series B | Information Technology, Software, Health Care | $1.2M–$51M |
|
UntroD Capital
VC Fund
|
22 | Japan, Singapore, Austria | Seed, Venture - Series Unknown, Series A | Manufacturing, Biotechnology, Health Care | $316k–$15M |
|
ANRI
VC Fund
|
21 | Japan, United States, Indonesia | Seed, Series A, Venture - Series Unknown | Software, Health Care, Information Technology | $268k–$41M |
|
Osaka University Venture Capital
VC Fund
|
19 | Japan | Seed, Venture - Series Unknown, Series A | Biotechnology, Health Care, Medical | $480k–$17M |
|
Fast Track Initiative, Inc.
VC Fund
|
19 | Japan, United States, United Kingdom | Series A, Series B, Seed | Health Care, Biotechnology, Medical | $345k–$117M |
|
Keio Innovation Initiative
VC Fund
|
14 | Japan, United Kingdom | Series A, Seed, Venture - Series Unknown | Health Care, Medical, Biotechnology | $826k–$41M |
|
Mizuho Capital
VC Fund
|
14 | Japan, United States, Singapore | Series A, Venture - Series Unknown, Series B | Information Technology, Software, Artificial Intelligence | $661k–$47M |
|
JAFCO
VC Fund
|
14 | Japan, United States, Israel | Series A, Series B, Venture - Series Unknown | Information Technology, Software, Artificial Intelligence | $1.3M–$71M |
|
UTEC - The University of Tokyo Edge Capital Partners
VC Fund
|
13 | Japan, United States, India | Seed, Series A, Series B | Health Care, Biotechnology, Medical | $900k–$20M |
|
Real Tech Japan
VC Fund
|
11 | Japan, Singapore, Austria | Venture - Series Unknown, Seed, Series A | Manufacturing, Biotechnology, Robotics | $316k–$21M |
|
SBI Investment
VC Fund
|
10 | Japan, South Korea, United States | Series B, Series A | Software, Information Technology, Financial Services | $1.9M–$60M |
|
Miyako Capital
VC Fund
|
10 | Japan, United States, United Kingdom | Series A, Seed, Series B | Medical, Biotechnology, Information Technology | $395k–$150M |
|
DBJ Capital
VC Fund
|
10 | Japan, United States, Australia | Series A, Series B, Venture - Series Unknown | Software, Health Care, Biotechnology | $1.1M–$57M |
|
Japan Science and Technology Agency
VC Fund
|
9 | Japan | Series A, Seed, Venture - Series Unknown | Biotechnology, Medical, Manufacturing | $1.4M–$18M |
|
Nissay Capital
VC Fund
|
8 | Japan, United States, Ethiopia | Seed, Series A | Health Care, Information Technology, Medical | $457k–$21M |
|
Nippon Venture Capital
VC Fund
|
8 | Japan, United States, Indonesia | Series A, Series B | Software, Health Care, Information Technology | $1.5M–$45M |
|
DG Daiwa Ventures
VC Fund
|
8 | Japan, United States, India | Seed, Series A, Venture - Series Unknown | Software, FinTech, Artificial Intelligence | $367k–$19M |
|
Angel Bridge
VC Fund
|
7 | Japan | Series A, Seed, Series B | Information Technology, Software, Consulting | $648k–$47M |
|
Miraidoa
VC Fund
|
7 | Japan, United States, Myanmar | Venture - Series Unknown, Seed, Series A | Manufacturing, Health Care, Information Technology | $96k–$11M |
|
Kyogin Lease & Capital
VC Fund
|
7 | Japan | Series A, Venture - Series Unknown, Seed | Manufacturing, Medical, Information Technology | $90k–$16M |
|
Senshu Ikeda Capital
VC Fund
|
6 | Japan | Venture - Series Unknown, Series A, Seed | Software, Manufacturing, Internet | $395k–$17M |
|
IT-Farm
VC Fund
|
6 | United States, Japan, Germany | Seed, Series A, Series B | Software, Health Care, Medical | $1M–$36M |
|
Incubate Fund
VC Fund
|
6 | Japan, United States, India | Seed, Series A | Software, Information Technology, E-Commerce | $317k–$20M |
|
FFG Venture Business Partners
VC Fund
|
5 | Japan, Indonesia, United States | Series A, Venture - Series Unknown, Seed | Software, Artificial Intelligence, Health Care | $547k–$50M |
|
Global Brain Corporation
VC Fund
|
5 | Japan, United States, United Kingdom | Series A, Series B | Software, Information Technology, Artificial Intelligence | $2M–$48M |
|
JIC Venture Growth Investments
VC Fund
|
5 | Japan, Singapore, United States | Series B, Series C | Information Technology, Software, Medical | $4.3M–$77M |
|
D3
VC Fund
|
5 | Japan, United States | Series A, Seed, Series B | Biotechnology, Therapeutics, Manufacturing | $690k–$51M |
|
F-Prime
VC Fund
|
5 | United States, United Kingdom, China | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $8M–$150M |
|
Tohoku University Venture Partners
VC Fund
|
4 | Japan, China | Venture - Series Unknown, Seed, Series A | Manufacturing, Medical, Biotechnology | $271k–$8.8M |
|
Capital Medica Ventures
VC Fund
|
4 | Japan | Seed, Series A, Venture - Series Unknown | Health Care, Medical, Software | $91k–$51M |
|
Eight Roads Ventures
VC Fund
|
4 | United States, China, India | Series B, Series A, Series C | Health Care, Software, Biotechnology | $6M–$117M |
|
Delight Ventures
VC Fund
|
4 | Japan, United States, South Korea | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $556k–$19M |
|
Fujifilm
VC Fund
|
4 | Japan, United States, China | Series A, Venture - Series Unknown, Corporate Round | Biotechnology, Health Care, Medical | $1.3M–$1.7B |
|
Daiwa Corporate Investment
VC Fund
|
4 | Japan, United States, France | Venture - Series Unknown, Series A, Seed | Software, Manufacturing, Health Care | $310k–$9.2M |
|
Remiges Ventures
VC Fund
|
4 | United States, Japan, Canada | Series A, Series B, Seed | Biotechnology, Medical, Health Care | $2.6M–$41M |
|
Tsukuba Institute of Research
VC Fund
|
4 | Japan | Series A, Seed | Medical, Manufacturing, Health Care | $953k–$7.1M |
|
Glocalink
VC Fund
|
4 | Japan, Singapore, United Kingdom | Seed, Venture - Series Unknown | Health Care, Robotics, Biotechnology | $43k–$3.3M |
|
SBI Group
VC Fund
|
4 | Japan, United States, United Kingdom | Series A, Series B | Financial Services, FinTech, Information Technology | $2.8M–$62M |
|
SPARX Group
VC Fund
|
3 | Japan, United States, United Kingdom | Venture - Series Unknown, Series B, Series A | Software, Artificial Intelligence, Information Technology | $2.5M–$142M |
|
Green Core
VC Fund
|
3 | Japan | Series A, Seed | Pharmaceutical, Health Care, Medical | $2M–$4.8M |
|
Darwin Venture Management
VC Fund
|
3 | Taiwan, United States, Japan | Seed, Series A | Software, Manufacturing, Information Technology | $1M–$76M |
|
WASEDA University Ventures
VC Fund
|
3 | Japan, United States, United Kingdom | Seed, Series A, Convertible Note | Medical, Biotechnology, Information Technology | $1.2M–$38M |
|
Sosei CVC
VC Fund
|
3 | Japan | Series A, Series B | Biotechnology, Medical, Pharmaceutical | |
|
Leave a Nest
VC Fund
|
3 | Japan, Singapore, Malaysia | Seed, Corporate Round, Series B | Artificial Intelligence, Software, Health Care | $36k–$4.7M |
|
Euglena
VC Fund
|
3 | Japan, United States | Seed, Series A, Venture - Series Unknown | Health Care, Biotechnology, Food and Beverage | $527k–$5.6M |
|
NEDO
VC Fund
|
3 | Japan, United States | Grant, Series A, Seed | Medical, Health Care, Biotechnology | $800k–$26M |
|
STRIVE
VC Fund
|
3 | Japan, India, Indonesia | Seed, Series A, Series B | Software, SaaS, Internet | $740k–$43M |
|
Higin Capital
VC Fund
|
3 | Japan | Series A, Series B, Venture - Series Unknown | Medical, Biotechnology, Software | $279k–$17M |
|
Chugin Capital Partner
VC Fund
|
3 | Japan | Series A, Seed, Venture - Series Unknown | Manufacturing, Software, Information Technology | $246k–$7.1M |
| Access all 720 investors in Japan Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Series A, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 668
- Round size: Series A $1.2M–$29M; Series B $3.5M–$38M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $94M in 2020
Portfolio highlights
- ADiXi — Adixi is a tech-driven business that supports the idea that people and technology may work together. It strives to open doors by utilizing cutting-edge technology, such as artificial intelligence, to promote long-term, sustainable corporate and societal progress.
- Caguuu — Caguuu offers high-quality designer furniture at affordable prices, through e-commerce, eliminating middlemen and store operating costs.
- Luxna Biotech — Luxana Biotech is a biotechnology firm dedicated to promoting the practical use of safe and effective nucleic acid therapies. Utilizing nucleic acid chemistry technology, the company strives to provide nucleic acid medicines to patients suffering from diseases that currently lack effective treatments.
Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Series A, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 652
- Round size: Series A $1.2M–$51M; Series B $2.3M–$40M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Etaily — Etaily provides e-commerce and retail solutions in the Philippines, enabling brands with end-to-end services, from store management to fulfillment.
- Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
- Josan-shes — Josan shes is web start up that offers nursing service to women and babies.
UntroD Capital is an R&D-based innovative technology that specializes in social implementation.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Health Care
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Japan, Singapore, Austria
Investor stats
- Total investments: 145
- Round size: Seed $316k–$6M; Series A $2.1M–$15M; Venture - Series Unknown $451k–$10M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Eco-Pork — Eco-Pork is a co-creation solution farm that supports farmers' food productivity improvement. It is connecting the pig and technology, pork ( Pork ) new business ecosystems ( Ecosystem By building a), in the pork growing demand around the world, to get the most out of the food supply capacity is finite.
- Teragen Energy — Teragen Energy develops an energy technology platform based on advanced regenerative solid oxide fuel cells that provide both power generation and energy storage in a single system. The company’s systems generate electricity from external fuels such as natural gas or hydrogen without combustion and can operate in reverse to store power as hydrogen.Teragen designs modular systems that can be scaled from megawatt-scale installations for data centers to deployments for microgrids, renewable projects, and utilities. Its technology is intended to help operators manage variable renewable output, ride through outages, and address daily capacity needs using one device. Teragen focuses on applications including AI and cloud data centers, manufacturing and cold storage facilities, remote communities, and electric grid infrastructure. The platform is positioned to replace separate diesel generators and battery systems by combining fuel-flexible generation and low-cost storage in a compact footprint.
- IGrid Solutions — IGrid Solutions will promote “eDCM” to optimize power energy demand.
ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Japan, United States, Indonesia
Investor stats
- Total investments: 311
- Round size: Seed $268k–$9.9M; Series A $967k–$41M; Venture - Series Unknown $616k–$28M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely still investing — raised $102M in 2022
Portfolio highlights
- Any Style — Any Style develops a messaging app from voice actors that regularly sends messages via subscription. It also engages in the planning and production of audio content and the VTuber production business.
- Arrowsmith — Arrowsmith is committed to unlocking the full potential of bacteriophages to revolutionize the treatment of bacterial infectious diseases. Through transformative science, Arrowsmith strive to create a world free from the pain and fear caused by antimicrobial resistance.
- Typewriter Therapeutics — Typewriter Therapeutics, Inc. develops mRNA-based gene therapies using a gene writing, or gene writing, platform for precise insertion of therapeutic genes into the genome. The company builds on transposon-based technologies originating from research by Professor Emeritus Haruhiko Fujiwara at the University of Tokyo. Its programs focus on all‑RNA,nonviral gene writing systems that repurpose natural genetic elements to address severe genetic disorders with limited treatment options. Typewriter Therapeutics conducts research and development across its U.S. and Japan operations and collaborates with investors and partners to advance genetic medicine candidates toward the clinic.
Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Japan
Investor stats
- Total investments: 92
- Round size: Seed $480k–$4.5M; Series A $1.5M–$17M; Venture - Series Unknown $685k–$3.5M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — raised $92M in 2021
Portfolio highlights
- JiMED — JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication.
- LQUOM — QWAVE offers cryptography communication technology.
- Toregem BioPharma — Toregem BioPharma is a startup from Kyoto University that develops a treatment for congenital adentia. Toregem BioPharma is headquartered in Kyoto, Japan.
Fast Track Initiative is a venture capital firm with an exclusive focus on life sciences and healthcare services.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Seed
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 84
- Round size: Seed $345k–$117M; Series A $3M–$51M; Series B $4.7M–$83M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $124M in 2021
Portfolio highlights
- NovAccel — NovAccel operates as a deep tech company, ensure a stable supply of medical radioisotopes.
- Storm Therapeutics — Targeting pathways that modify RNA to deliver novel cancer therapeutics.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Japan, United Kingdom
Investor stats
- Total investments: 91
- Round size: Seed $826k–$14M; Series A $2.2M–$41M; Venture - Series Unknown $1.6M–$12M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $94M in 2020
Portfolio highlights
- ElleThermo — elleThermo aims to implement Semiconductor-Sensitised Thermal Cells (STCs), an energy conversion technology that can generate electricity from unused waste heat above room temperature.
- Starlight Engine — Starlight Engine develops and commercializes fusion energy power plant technologies.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Series A, Venture - Series Unknown, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 537
- Round size: Series A $1.4M–$41M; Series B $2.4M–$47M; Venture - Series Unknown $661k–$11M
- Lead/follow: 5% lead, 95% follow
- Last fund: May invest from a new fund soon — raised $92M in 2020
Portfolio highlights
- CaTe — CaTe is based in Tokyo. CaTe develops and manufactures a Digital Therapeutic (DTx) for remote cardiac rehabilitation. Their invention allows heart disease patients to safely and successfully complete cardiac rehabilitation utilizing standing exercise in a confined space, such as at home, without the use of ergometers or similar instruments.
- Paytner — Paytner is providing services to support freelance people's funding. The freelance population in Japan has been shown to continue to increase in many Chosa. While working styles are diversified, they are not able to respond to the development of the working environment, and they will develop their business to change the situation whereproblems such as funding, credit, sexual harassment, and power harassment are accumulated.
- Power Laser — Power Laser is a startup company that offers a range of power laser technologies and applications. The company develops high-power laser systems, related components, and software for advanced industrial and scientific applications. Its mission, “Power lasers open the future,” reflects its focus on next-generation photonics and precision laserinnovation for manufacturing and research sectors.
Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to thecreations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Japan, United States, Israel
Investor stats
- Total investments: 337
- Round size: Series A $2.4M–$71M; Series B $5M–$36M; Venture - Series Unknown $1.3M–$27M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $567M in 2019
Portfolio highlights
- ADiXi — Adixi is a tech-driven business that supports the idea that people and technology may work together. It strives to open doors by utilizing cutting-edge technology, such as artificial intelligence, to promote long-term, sustainable corporate and societal progress.
- EISHIN — EISHIN is a technology company that specializes in pet tech business, recruitment consulting, website creation, and development services.
- Yokohama Vanilla — Yokohama Vanilla is a Company which operates Yokohama-based gift sweets brand.
UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Series B
- Geography: Japan, United States, India
Investor stats
- Total investments: 209
- Round size: Seed $900k–$14M; Series A $2.3M–$18M; Series B $2.8M–$20M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely actively investing — fresh fund, raised $326M in 2025
Portfolio highlights
- Mujin — At Mujin, we design automation platforms to enhance any robot, enable advanced capabilities and lower operating costs.
- Sinumy — Sinumy develops touchless identity authentication technology and high-speed, high-precision position measurement technology.
- X Mile — Corporate Site:https://www.xmile.co.jp/ Service Site:https://x-work.jp/
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Real Tech Japan is a venture capital firm that seeks to invest in innovative R&D technology companies. Realtech Fund is a joint venture between the Ministry of Economy, Trade, and Industry and NEDO (New Energy and Industrial Technology Development Organization). The firm was founded in 2014 and based in Tokyo, Japan.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Robotics
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: Japan, Singapore, Austria
Investor stats
- Total investments: 79
- Round size: Seed $316k–$5M; Series A $2.1M–$21M; Venture - Series Unknown $438k–$10M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Ashirase — Ashirase is a developer of a walking navigation system for the visually challenged. The company assists visually impaired people in walking independently. This also allows the user to have more attention to spare for audible warnings in their environment. It includes voice input and guidance via a smartphone app. A vibration interface is attachedto their shoes.
- Ken Robotec — Ken Robotec provides labor-saving solutions that promote productivity improvement and reduce the burden on workers at construction sites. The company contributes to the evolution and development of the construction industry. The objective of Ken Robotec is to create a joyful construction site where robots and humans may collaborate.
- MaterialGate — MaterialGate focuses on single-molecule dielectrics, developing technologies for devices with better electronic characteristics.
SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.
Show more...Investment focus
- Industry: Software, Information Technology, Financial Services
- Stage:Series B, Series A
- Geography: Japan, South Korea, United States
Investor stats
- Total investments: 452
- Round size: Series A $1.9M–$29M; Series B $4.5M–$60M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $77M in 2020
Portfolio highlights
- LQUOM — QWAVE offers cryptography communication technology.
- Alxtal — Alxtal is a tech company who optimize the development, design, and manufacturing processes of the manufacturing industry with IT and AI.
- Zerodoor HD — Zerodoor HD specializes in digital transformation in constructing industry.
Miyako Capital is the venture capital that manages Kyoto University 2nd Venture Fund (KUVF). The company was founded in 2013 and based in Kyoto & Tokyo, Japan. Investment fields are: 1) Life Science, Biotechnology: Drug creation, regenerative medicine, medical beauty equipment, medical services.2) Agri-Food: Industrialization,agricultural and fishery products growth-promoting technology, specified health food, health food.3) Environment, Energy: Alternative energy, and related technologies.4) IT, Electronics: Web, mobile related devices and application, telecommunication technology, security, consumer and business oriented application, mechatronic, robot.5) New services utilizing state-of-art technology.Investment stages: Primary investment stages are initial-growth stages of seed and early. However, we aim at all growth stages and make investment in post-IPO portfolio companies as well as public companies that are related with Kyoto University.
Show more...Investment focus
- Industry: Medical, Biotechnology, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 52
- Round size: Seed $395k–$19M; Series A $2.3M–$28M; Series B $3.7M–$150M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $91M in 2019
Portfolio highlights
- Mui Lab — Mui is an aesthetically-pleasing wooden IoT device connected to a cloud service. By accessing information through natural wood, we can rethink a new type of lifestyle.
- Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
- XFOREST Therapeutics — xFOREST Therapeutics develops a drug discovery platform that targets RNA structures.
DBJ Capital Co., Ltd. was founded in June 2010 through the integration of two venture capital firms of the DBJ Group, New Business Investment Co., Ltd. and Intellectual Properties Development & Investment, Inc. We are a wholly-owned subsidiary of Development Bank of Japan Inc.At DBJ Capital, we focus on venture firms which use newtechnologies and business models to grow and compete on the global market, regardless of their industry or scale. To meet the particular needs of each client, we mobilize the entire DBJ Group to arrange the best investment solutions, ranging from growth-spurring equity investment to financing schemes drawing on DBJ's vast networks.We also assist in venture start-ups. Our value enhancement team provides the kind of comprehensive, hands-on support needed to commercialize outstanding intellectual property and technologies developed by firms, research labs, and universities, and to carve out a place for them in the market.DBJ Capital will continue to play in a part in Japan's economic revival - by helping the firms we invest in to grow, and by encouraging the creation of new industries in Japan.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Japan, United States, Australia
Investor stats
- Total investments: 164
- Round size: Series A $2.4M–$57M; Series B $4.6M–$34M; Venture - Series Unknown $1.1M–$9.5M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Creattura — Creatura assists companies in reducing greenhouse gas emissions by generating and distributing carbon credits and promoting the adoption of renewable energy sources.
- Power Laser — Power Laser is a startup company that offers a range of power laser technologies and applications. The company develops high-power laser systems, related components, and software for advanced industrial and scientific applications. Its mission, “Power lasers open the future,” reflects its focus on next-generation photonics and precision laserinnovation for manufacturing and research sectors.
- Kyoto Fusioneering — Kyoto Fusioneering is a research & development, design, and manufacture of parts related to fusion reactors.
Japan Science and Technology Agency is an integrated organization of science and technology that implements science and technology policy in Japan. It handles many projects, including the government’s Science and Technology Basic Plan and knowledge creation. The European Sustainability School ESSSR is the owner of Japan Science and TechnologyAgency.Japan Science and Technology Agency undertakes its task in a comprehensive manner. It also works to provide a sound infrastructure of science and technology information and raise awareness and understanding of science and technology-related issues in Japan.Japan Science and Technology Agency is headquartered in Tokyo, Japan.
Show more...Investment focus
- Industry: Biotechnology, Medical, Manufacturing
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Japan
Investor stats
- Total investments: 56
- Round size: Seed $1.7M–$5M; Series A $2.3M–$18M; Venture - Series Unknown $1.4M–$9.8M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Triorb — The corporate website of TriOrb Inc., revolutionizing production lines with our ball-driven omnidirectional mobility platform.
- ANRis — ANRis is a hybrid drug discovery venture that develops medicines to provide medical care for patients with cancer and genetic diseases.
- Solaris — Solaris commercializes, manufactures, and sells soft robotics using pneumatic artificial muscles. Solaris was founded in 2017 and was headquartered in Tokyo, Japan.
Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.
Show more...Investment focus
- Industry: Health Care, Information Technology, Medical
- Stage:Seed, Series A
- Geography: Japan, United States, Ethiopia
Investor stats
- Total investments: 306
- Round size: Seed $457k–$21M; Series A $1.2M–$12M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $92M in 2019
Portfolio highlights
- OptQC — OptQC commercializes cutting-edge optical quantum computing technologies developed by the Furusawa-Endo Laboratory. Because optical quantum computers are more scalable than superconducting and other quantum computing implementations, OptQC's optical quantum computers should reach this scale. They also have benefits like faster processing andreduced power consumption, which makes optical quantum computers a possible long-term pinnacle of quantum technology.
- Zeal Boxing Fitness — Zeal Boxing Fitness combines power of sports with the power of technology to provide a service that allows to enjoy fitness.
- Global Trust Networks — GTN is a Japanese real estate brokerage firm. Foreigners can use the company's rent guarantee and real estate rental brokerage services to acquire brokerage services at a low cost.
Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Series B
- Geography: Japan, United States, Indonesia
Investor stats
- Total investments: 194
- Round size: Series A $1.5M–$45M; Series B $3.3M–$33M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — raised $15M in 2023
Portfolio highlights
- KUZEN — KUZEN provides enterprise-grade chatbot technologies, especially the bot framework and NLP, via a visual UI without coding. The company is utilizing technology to develop a system that broadens the scope of dialogue. They use technology to provide their customers with next-generation standard procedures that broaden the possibilities ofconversation, resulting in unprecedented business practices.
- AOI Biosciences — AOI Biosciences is a biotechnology company that creates testing and drug discovery businesses.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
DG Daiwa Ventures invests in start-up companies with next-generation technology and provides business development support. It is focused on blockchain, xR, AI, security, and BioHealth, as they are likely to be at the foundations of future businesses. In addition to the five core technologies, the fund will also focus on IoT technologies, whichoften overlap or serve as an application layer.
Show more...Investment focus
- Industry: Software, FinTech, Artificial Intelligence
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Japan, United States, India
Investor stats
- Total investments: 89
- Round size: Seed $679k–$6M; Series A $3M–$10M; Venture - Series Unknown $367k–$19M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- New Chat — New Chat is a technology company that develops communication software focused on visual and interactive group interactions. The company builds platforms designed to help small, close-knit groups of people share daily experiences through short-form multimedia content. Its primary software automates the creation of collaborative video logs byprompting users for brief, periodic updates throughout the day. By structuring messaging around shared visual moments, the business aims to provide an alternative to traditional text-based group chats and standard social media networking.
- First Coffee — Discover the best specialty coffee in India with our range of single origin Arabica beans and exclusive merchandise. Shop online at First Coffee for freshly roasted, quality blends.
- Tellus Global — Tellus Global is a company focused on creating new businesses using satellite data, AI, and software technologies,Its core mission is to make satellite information accessible and useful across industries such as agriculture, environmental conservation, construction, finance, and disaster management.
Angel Bridge is a angel investor groups in Japan and provide high quality and abundant funds to excellent companies.
Show more...Investment focus
- Industry: Information Technology, Software, Consulting
- Stage:Series A, Seed, Series B
- Geography: Japan
Investor stats
- Total investments: 77
- Round size: Seed $648k–$10M; Series A $2.5M–$19M; Series B $6.5M–$47M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $10M in 2019
Portfolio highlights
- PeopleX — PeopleX encourages and assists employees in their professional development.
- Paytner — Paytner is providing services to support freelance people's funding. The freelance population in Japan has been shown to continue to increase in many Chosa. While working styles are diversified, they are not able to respond to the development of the working environment, and they will develop their business to change the situation whereproblems such as funding, credit, sexual harassment, and power harassment are accumulated.
- Power Laser — Power Laser is a startup company that offers a range of power laser technologies and applications. The company develops high-power laser systems, related components, and software for advanced industrial and scientific applications. Its mission, “Power lasers open the future,” reflects its focus on next-generation photonics and precision laserinnovation for manufacturing and research sectors.
Future Venture Capital Co., Ltd. is a venture capital firm specializing in early stage investment. The firm invests in diversified investment in a broad range of industrial sectors. It seeks to invest in Japan. The firm prefers to be the lead investor in its portfolio companies. Future Venture Capital Co., Ltd. was founded in 1998 and is based inKyoto, Japan with offices in Tokyo, Aomori, Iwate, Yamagata, Kanazawa, Mie, Sakai, Kobe, and Ehime.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Information Technology
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: Japan, United States, Myanmar
Investor stats
- Total investments: 170
- Round size: Seed $338k–$5.3M; Series A $1.2M–$11M; Venture - Series Unknown $96k–$4.6M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $2.5M in 2020
Portfolio highlights
- Naorai — Naorai is a food and beverage firm that manufactures wine, beer, spirits, and non-alcoholic beverages.
- Sinumy — Sinumy develops touchless identity authentication technology and high-speed, high-precision position measurement technology.
- Dioseve — Dioseve is providing novel possibilities for all life.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Kyogin Lease & Capital is an investment firm that specializes in the leasing, stock and bond investment and public offering consulting.
Show more...Investment focus
- Industry: Manufacturing, Medical, Information Technology
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Japan
Investor stats
- Total investments: 36
- Round size: Seed $91k–$3.8M; Series A $1.1M–$16M; Venture - Series Unknown $90k–$9M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — raised $9M in 2019
Portfolio highlights
- TSK Corporation — TSK is a manufacturing company that develops organic synthesis technology to supply innovative and long-lasting catalysts to industries. The company develops and manufactures iron catalysts that are used in the production of agrochemicals, semiconductors, and pharmaceuticals, giving enterprises the option of switching from palladium catalysts tomore environmentally friendly iron catalysts.
- IKOU — IKOU is an inclusive brand for babies and children that creates products valued by all users. The company's featured products include portable seats, bibs, and children's clothing products along with online services.
- Towing — Towing is an agricultural company that provides farming, manufacturing, and recycling services.
Senshu Ikeda Capital offers financial consultancy services.
Show more...Investment focus
- Industry: Software, Manufacturing, Internet
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 67
- Round size: Seed $395k–$3.8M; Series A $1.9M–$17M; Venture - Series Unknown $443k–$10M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — raised $11M in 2019
Portfolio highlights
- JiMED — JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication.
- Molmir — Molmir is a biotech company that conducts research and develops treatments for intractable diseases based on sensing technology.
- LEP — LEP develops plants that glow without electricity.
IT-Farm is a venture capital firm which specializes in seed, start-up, and early stage companies. It primarily invests in mobile, big-data, connected car, IoT, OTT service, Helth care, Bio Tech and other IT industries. The firm actively invests in SF bay area and Japan, as well as other geometries including Asia and Europe. We support portfoliocompanies, especially on the partnership with Japanese enterprises.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United States, Japan, Germany
Investor stats
- Total investments: 135
- Round size: Seed $1M–$7.5M; Series A $1.6M–$16M; Series B $2.5M–$36M
- Lead/follow: 10% lead, 90% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Ubitus — As cloud gaming enablers, Ubitus' GPU virtualization, Streaming technology and hybrid cloud deployment can serve different kinds of solutions for Telco, Game companies to quick enter cloud gaming market. Moreover, Ubitus provide Global distribution and New Media content solution for new media studio and fashion brand to help them distribute rich media contents worldwide.
- POPS Worldwide — POPS Worldwide is the leading digital entertainment company in Southeast Asia. With over 4 billion monthly views of its music and entertainment content, POPS is the fastest growing digital entertainment media company with hundreds of artists, content creators and partners from broadcast television, publishing and production in the POPS Network.POPS also produces a wide variety of original content for its industry-leading owned and operated channels like POPS Music, POPS Kids, POPS TV, Beauty Me, HerVoice and CoolTV that target highly sought after demographics: teens, kids, women and men.
- Global Equipment Services — As a strategic partner to developers of multi-sector products, Averna provides innovative automated testing tool and quality assurance solutions.
Incubate Fund is an independent early-stage venture capital that specializes in providing capital to technology startups at the seed stage. The firm built a portfolio of over 300 companies in Asia, taking 12 companies to public and 20 companies to M&A exit since 2010.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Seed, Series A
- Geography: Japan, United States, India
Investor stats
- Total investments: 376
- Round size: Seed $317k–$10M; Series A $1.9M–$20M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely still investing — raised $127M in 2024
Portfolio highlights
- Akari Hosho — Akari Hosho provides a group of trusted professionals, including lawyers and judicial scriveners. Akari Hosho provides a guarantee service.
- Black Cat Carnival — Black Cat Carnival Inc. is a communication service development company.
- Carbon CryoCapture — Carbon CryoCapture specializes in the carbon dioxide separation systems aimed at creating economically viable, energy-efficient, and genuinely sustainable CO2 separation and recovery technologies. The company is dedicated to deploying cost-effective, efficient systems for CO2 capture that integrate smoothly with current infrastructures, all whileenhancing energy consumption and production. This enables clients to attain zero emissions throughout the development and application of resources.
FFG Venture Business Partners is a large-scale enterprise that offers in traditional regional bank venture capital.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Japan, Indonesia, United States
Investor stats
- Total investments: 87
- Round size: Seed $706k–$50M; Series A $1.2M–$8.9M; Venture - Series Unknown $547k–$10M
- Lead/follow: 10% lead, 90% follow
- Last fund: May invest from a new fund soon — raised $46M in 2020
Portfolio highlights
- MW — MW is a smart home solution company that develops smart residential physical AI, robotics, and home design services.
- InsightX — InsightX is a technology platform focused on empowering businesses by simplifying complex processes and enabling smarter, more personalized user experiences.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Global Brain Corporation is a venture capital firm that invests in companies from seed or early to pre-IPO startups. Global Brain has invested in 300+ startups from seed/early to pre-IPO startups and achieved 25 IPOs and 61 M&As as a result of providing hands-on support services and resources to its portfolio startups. Global Brain hasmanaged a pure investment fund as well as multiple corporate venture capital funds partnered together with tier 1 public companies of telecom, real estate development, financial service, beverages, agriculture food, logistics, and electronic devices.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 795
- Round size: Series A $2M–$31M; Series B $3.5M–$48M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely actively investing — fresh fund, raised $65M in 2025
Portfolio highlights
- Josys — Stop letting runaway SaaS costs & unsecured SaaS access ruin your day. Josys is the only SaaS Management Platform that provides true 360-degree control.
- Valt Japan — VALT JAPAN is a social business compan that continues to pursue solutions to social issues.
- Deeping Source — Real-time Video Analytics based on Data Anonymization. High-accuracy computer vision for large-scale spaces: hypermarkets, shopping malls, convention centers, hospitals, logistics warehouses, construction sites, etc.
JIC-VGI helps promote innovation and improve its international competitiveness through growth-investments in startup companies. The firm accelerating innovation and helping to solve industrial and social issues by supporting and seeking innovative technologies and new businesses.JIC Venture Growth Investments was established in July 2020 and isbased in Tokyo, Japan.
Show more...Investment focus
- Industry: Information Technology, Software, Medical
- Stage:Series B, Series C
- Geography: Japan, Singapore, United States
Investor stats
- Total investments: 112
- Round size: Series B $4.7M–$52M; Series C $4.3M–$77M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $1.1B in 2020
Portfolio highlights
- CaTe — CaTe is based in Tokyo. CaTe develops and manufactures a Digital Therapeutic (DTx) for remote cardiac rehabilitation. Their invention allows heart disease patients to safely and successfully complete cardiac rehabilitation utilizing standing exercise in a confined space, such as at home, without the use of ergometers or similar instruments.
- FLUX — FLUX provide “FLUX Header Bidding Solution” that creates fair competition opportunities and significantly increases advertising revenue within the header bidding server, ad requests are sent to SSPs and ad exchanges all at once, so it is possible to have a pure price competition without prioritization, and to determine the highest bid amount andvalue of the advertising space. I can. Then, the price of the highest bid ad in the header bidding and the ad set in the ad server are competed, and the ad with the higher bid is delivered.
- Strand Therapeutics — Clinical-stage biotech developing breakthrough mRNA therapeutics with targeted delivery systems for solid tumors, autoimmune diseases, and blood cancers.
DISCOVERY, DEVELOPMENT, DEPLOYMENT FOR GLOBAL HEALTH, WITH SCIENCE & BUSINESS ACUMEN
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Manufacturing
- Stage:Series A, Seed, Series B
- Geography: Japan, United States
Investor stats
- Total investments: 12
- Round size: Seed $1.6M–$2.8M; Series A $690k–$51M
- Lead/follow: 58% lead, 42% follow
Portfolio highlights
- Neumo — Neumo is a musical education-based firm that offers pitch measurement courses, programs, consulting, and tests.
- RevolKa — RevolKa manufactures bio-products pharmaceuticals intended to serve the healthcare sector.
- Neros Technologies — Neros is vertically integrating production of unmanned defense systems in the United States, securing the autonomous supply chain. Are you with us?
F-Prime Capital is a global venture capital firm investing in healthcare and technology, with a heritage that spans four decades.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, China
Investor stats
- Total investments: 534
- Round size: Series A $8M–$87M; Series B $15M–$112M; Series C $20M–$150M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Lemon Cash — Lemon Cash is digital wallet with FIAT and crypto capabilities. End to end digital ecosystem for Latin America.
- PlasmaGen Biosciences — PlasmaGen BioSciences is an Indian Bio-pharmaceutical organization specializing exclusively in Plasma Protein Therapy.Headquartered in Bangalore- India, PlasmaGen has been making every effort in the domain of Plasma product Industry and has become an Imperative one stop destination for the medical fraternity for most of the plasma products need.They have a basket of plasma products and the widest range of immunoglobulins in India catering to the requisites of various realms viz. Haematology, Oncology, Immunology, Paediatrics, Rheumatology, Dermatology and Neurology.
- Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
THVP is a venture capital corporation for startup innovation. It was established in 2015 and is based in Nagoya, Japan.
Show more...Investment focus
- Industry: Manufacturing, Medical, Biotechnology
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: Japan, China
Investor stats
- Total investments: 53
- Round size: Seed $271k–$2.5M; Series A $1M–$7.9M; Venture - Series Unknown $459k–$8.8M
- Lead/follow: 51% lead, 49% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Koeda — KOEDA is researching and developing medical devices that are safe, painless, and easy to use for acute cholecystitis. KOEDA will transform the management of cholecystitis. So far, endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) has been a notably difficult procedure carried out by skilled doctors at specific advanced centers. Althoughinserting a tube into the gallbladder is less invasive, it is complex, and there may be concerns regarding bile leakage. By combining clinical expertise with precision engineering, KOEDA addresses a clearly defined medical need in a growing global market and is currently moving forward on schedule for regulatory clearance and commercialization.
- Scohia Pharma — Scohia Pharma is a biotech venture that will have both substantial research and development resources and be nimble enough to make decisions quickly, will strive to improve patient quality of life by providing patients and healthcare professionals with new therapeutic medications for renal, metabolic.
- SiccaNova Therapeutics — SiccaNova Therapeutics is a Japanese biopharmaceutical company dedicated to treating sicca (dryness) related medical conditions. The company’s lead drug candidate, XF8302, is a novel, small-molecule M3 muscarine receptor Positive Allosteric Modulator (M3 PAM). Developed initially for dry mouth in Sjögren’s syndrome patients, the drug enhancesnatural acetylcholine signaling to stimulate salivation without the systemic side effects common in traditional agonists.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Capital Medica Ventures is a venture capital firm based in Tokyo, Japan with a focus on startups in the healthcare industry.Capital Medica Ventures is a venture capital that operates a venture fund specializing in the healthcare field. It is the only healthcare-specialized VC in Japan that can provide 30 medical institutions as a business trialfield.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Japan
Investor stats
- Total investments: 19
- Round size: Seed $91k–$1.1M; Series A $1.5M–$51M; Venture - Series Unknown $1.5M–$11M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — raised $12M in 2018
Portfolio highlights
- A-SEEDS — A-SEEDS, an innovative biotech company sprouted from Shinshu University, is dedicated to pioneering advanced treatments for life-threatening cancers. Harnessing the potential of non-viral genetic engineering, our cutting-edge immune cell therapy opens up new horizons of hope for patients seeking effective and transformative solutions.
- Do. Sukasu — Do. Sukasu is a software company that specializes in the development of visual space perception ability for brain science approaches.
- HEAL-lll — HEAL-lll is a multifaceted firm that merges healthcare, technology, and gamification to promote individual and organizational well-being.
Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: United States, China, India
Investor stats
- Total investments: 472
- Round size: Series A $6M–$51M; Series B $9.4M–$70M; Series C $10M–$117M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $350M in 2022
Portfolio highlights
- GoodData.AI — GoodData is a leading composable data and analytics platform. Build, embed, and scale analytics on demand, with zero vendor lock-in.
- specsmakers — Buy Eyeglasses, Eyeglass Frames, Computer Glasses, Contact Lenses, Sunglasses online at Specsmakers. Latest Collection of Frames. Free Shipping. Secure checkout. 14 Days Return Policy.
- PlasmaGen Biosciences — PlasmaGen BioSciences is an Indian Bio-pharmaceutical organization specializing exclusively in Plasma Protein Therapy.Headquartered in Bangalore- India, PlasmaGen has been making every effort in the domain of Plasma product Industry and has become an Imperative one stop destination for the medical fraternity for most of the plasma products need.They have a basket of plasma products and the widest range of immunoglobulins in India catering to the requisites of various realms viz. Haematology, Oncology, Immunology, Paediatrics, Rheumatology, Dermatology and Neurology.
Delight Ventures is a venture capital firm that thoroughly reduces the hurdles of entrepreneurship in Japan and supports entrepreneurs in the world. Entrepreneurship is taken as a natural career path, and we aim to be a society where both successful and unsuccessful people can continue to take on challenges.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Japan, United States, South Korea
Investor stats
- Total investments: 89
- Round size: Seed $556k–$4.3M; Series A $1.9M–$11M; Series B $3.1M–$19M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $93M in 2019
Portfolio highlights
- Ababa — Ababa provides recruitment and employment solutions.
- CraftBank — CraftBank, Inc. is the start-up that operates online matching platform between constructors with having relations with 22k specialty constructors (10% coverage in the market). The company was succeeded in Management BuyOut in April 2021.
- Josh Collaboration — Josh Collaboration is a software company that provides mailing, fax transmission, and partner management services.
Fujifilm develops and sells consumer products and business products related to photography. Fujifilm Holdings Corporation is a Japanese multinational photography and imaging company. The company serves various industries, including medical, graphic arts, optics, enterprise storage, motion picture, and photography.The company’s consumer productsare categorized as digital cameras and accessories, film photography, Instax photography, and binoculars. Its business products are categorized as medical systems, Fujinon endoscopy, microfilm, data storage, graphic arts and printing, professional video, optical devices, specialty chemicals, printing imaging colorants, and more. Color films, digital cameras, photofinishing equipment, color papers, photofinishing chemicals, medical imaging equipment, graphic arts equipment and materials, flat panel displays, and photocopiers and printers are some products developed by Fujifilm USA.Fujifilm USA is based in Minato-ku, Tokyo, Japan.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Venture - Series Unknown, Corporate Round
- Geography: Japan, United States, China
Investor stats
- Total investments: 25
- Round size: Series A $3.3M–$250M; Corporate Round $1.3M–$1.7B; Venture - Series Unknown $2.9M–$36M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Ripcord — Ripcord turns documents into powerful data. As a disruptor in the document intelligence market, Ripcord’s AI-driven platform harnesses proprietary robotics, generative AI, and cloud software to digitize and accurately derive vital information from paper and digital documents. Founded out of NASA research, Ripcord is backed by leading investorsincluding Kleiner Perkins, Google Ventures, Icon Ventures, Lux Capital, MUIP, and Apple co-founder Steve Wozniak.
- Rapidus — Rapidus is an Electronic component research, development, design, production, and sales that includes semiconductor elements and integrated circuits. Environmentally friendly, energy-saving semiconductors and semiconductor manufacturing technology are being researched and developed. Human resource development and training for the semiconductorsector.
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Daiwa Corporate Investment is a private investment firm of Daiwa Securities Group that has been engaged in overseas VC investments by taking advantage of an extensive business network in Japan and foreign countries, long experience and professional knowledge, and by supporting the growth of a number of overseas portfolio companies and their stockexchange listings.
Show more...Investment focus
- Industry: Software, Manufacturing, Health Care
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: Japan, United States, France
Investor stats
- Total investments: 141
- Round size: Seed $310k–$1.3M; Series A $1.1M–$6.9M; Venture - Series Unknown $910k–$9.2M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $90M in 2018
Portfolio highlights
- NovAccel — NovAccel operates as a deep tech company, ensure a stable supply of medical radioisotopes.
- AstroX — AstroX is a private space startup company that develops satellite launch vehicles for space development. It utilizes the rockoon method for developing launch vehicles and small rockets to help clients easily use space.
- Sonire Therapeutics — SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU) therapy system that will employ acoustic engineering (ultrasound) technologies developed through cutting-edge academic research. SONIRE has been working on a next-generation high-intensity focused ultrasound (HIFU) treatment system as a noveltherapeutic modality with the goal of giving cancer patients and their families a new future.
Remiges Ventures is a venture capital firm that focuses on groups and businesses in the Japanese academia and pharmaceutical industry.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B, Seed
- Geography: United States, Japan, Canada
Investor stats
- Total investments: 25
- Round size: Seed $2.6M–$10M; Series A $6.8M–$25M; Series B $8.2M–$41M
- Lead/follow: 64% lead, 36% follow
- Last fund: May invest from a new fund soon — raised $95M in 2019
Portfolio highlights
- Kupando — Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.
- Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
- Restore Vision — Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.
Tsukuba Institute of Research (筑波総研) is an R&D center owned by housing and wood products group Sumitomo Forestry. The facility develops technologies to make more effective use of wood in a wide range of fields.
Show more...Investment focus
- Industry: Medical, Manufacturing, Health Care
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 10
- Round size: Seed $953k–$1.8M; Series A $2M–$7.1M
- Lead/follow: 10% lead, 90% follow
- Last fund: May invest from a new fund soon — raised $4.5M in 2019
Portfolio highlights
- LIGHTz — LIGHTz delivers a technology transfer and information exchange platform leveraging AI.
- Celaid Therapeutics — Celaid Therapeutics develops technologies and products based on hematopoietic stem cell (HSC) expansion and gene-augmented therapies. The company operates a platform that enables in-vitro propagation of human HSCs without relying on animal-derived components, facilitating scalability, consistency, and cost control. It applies this platform acrossworkflows, including donor/patient cell collection, HSC expansion, cell processing, and gene editing to deliver cell therapy products. Celaid advances pipelines in areas such as blood cancers, genetic disorders, and rare hematologic diseases. Through partnerships and internal research, it seeks to support both reagent/media supply and therapeutic development around HSC-based regenerative medicine.
- Veneno Technologies — Veneno Technologies develops drug candidates for pharmaceutical companies. The company provides services that include the treatment of neurological, cardiovascular, and metabolic diseases, cancer cell proliferation, metastasis, and immune cell regulation.
OUR STRATEGY Members of Glocalink have extensive experi
Show more...Investment focus
- Industry: Health Care, Robotics, Biotechnology
- Stage:Seed, Venture - Series Unknown
- Geography: Japan, Singapore, United Kingdom
Investor stats
- Total investments: 19
- Round size: Seed $43k–$3.3M; Venture - Series Unknown $128k–$1.9M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- MOVeLOT — MOVeLOT is an AI company that provides skeletal platform and robot planning, development, and production services.
- Kisui Tech — Kisui Tech is an agricultural AI robotics company that help farmers for farming.
- LYMPHOGENiX — LYMPHOGENiX is the pioneer company for lymphatic vessels regeneration. Our proprietary technology revitalizes the function of lymphatic vessels, making us experts in treating various health conditions. Our treatment is also great for skin-aging, obesity, Alzheimer's diseases and infertility. We believe in helping our clients improve their vitality and energy, one treatment at a time.
SBI Group aims to become a corporate entity that provides a variety of one-stop financial services over the Internet now that two major events, the Financial Big Bang resulting from deregulation, and the Internet Revolution resulting from IT innovation, have radically transformed the financial industry.
Show more...Investment focus
- Industry: Financial Services, FinTech, Information Technology
- Stage:Series A, Series B
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 171
- Round size: Series A $2.8M–$62M; Series B $7M–$54M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- Ajaib — Mulai investasi online dengan Ajaib. Platform investasi terpercaya yang aman, sudah berizin dan diawasi OJK & BAPPEBTI. Download aplikasinya & daftar sekarang!
- Fasset — Fasset is an all-in-one financial super app that allows people and businesses to receive money, invest, earn, and make payments from anywhere in the world.
- GeoDreams — GeoDreams is a clean energy and geothermal technology company focused on next-generation closed-loop geothermal power generation.
SPARX Group Co., Ltd. is an independent Asia-based equity and credit asset management services and Asian fund financial specialist with offices in Tokyo, Hong Kong and Seoul for global institutional and individual investors, including financial advisors and financial planners, with alternative strategies (including activist, short-enabled, private equity and quantitative and fund-of-funds) and mutual funds (through SPARX Asia Funds such as SPARX Asia Pacific Opportunities Fund, SPARX Asia Pacific Equity Income Fund, SPARX Japan Smaller Companies Fund and SPARX Japan Fund) managed or sub-advised by SPARX Asset Management Co. Ltd., SPARX Asia Investment Advisors Limited and Cosmo Asset Management Co., Ltd.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Venture - Series Unknown, Series B, Series A
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 84
- Round size: Series A $3.7M–$142M; Series B $4.6M–$48M; Venture - Series Unknown $2.5M–$13M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $128M in 2018
Portfolio highlights
- Provigate — PROVIGATE is a provider of bio-transistor sensor technologies in Japan.The company's technologies are able to measure dynamic changes with the help of perception-broadening sensors, enabling individuals to change their habits for health
- Spaceflux — As satellites become increasingly vital, Spaceflux tackles the growing challenges of orbital congestion and debris that put them at risk. Thanks to our proprietary global network of optical sensors, we provide data-driven space situational awareness services from LEO to Cislunar.
- Alloyed — OxMet Technologies develops, licenses, and manufactures proprietary alloys, alloy powders and alloy components for the aerospace, automotive, industrial and biomedical markets.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Green Core is an investment firm.
Show more...Investment focus
- Industry: Pharmaceutical, Health Care, Medical
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 8
- Round size: Series A $2M–$4.8M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- JiMED — JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication.
- Cosomil — Cosomil develops early diagnostic drugs for diseases and provides research and development support to healthcare companies.
- Physiologas Technologies — Physiologas Technologies is a manufacturing company that designs and develops medical equipment for the healthcare industry.
Darwin Venture Management is a venture capital firm headquartered in Taipei, Taiwan, with offices in Hsinchu and the United States. Since our founding in 2009, we have managed eight funds, investing primarily in Series A/B, late-stage, and secondary funds. In 2022, we also launched an evergreen angel fund to enable more nimble bets onpromising early-stage teams, and especially those coming from Taiwan’s superb academic and research institutions. This exposure across stages and borders, coupled with the strong technical background of our team, is the source of Darwin’s differentiation. We recently launched our 8th fund Darjune.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Series A
- Geography: Taiwan, United States, Japan
Investor stats
- Total investments: 146
- Round size: Seed $1M–$3.1M; Series A $3M–$76M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Phamily — Full-service care transformation powered by 10+ years of experience, a dedicated clinical workforce, and our AI-enabled platform.
- BitBiome — BitBiome is a microbiome analysis company that aims to discover and understand disease-linked microorganisms. Its, single-cell whole-genome analysis platform specifically targets microbes and can be used on uncultured, raw samples, providing unprecedented strain-level quantitative and functional insights.THe company was founded in 2018 and isbased in Japan.
- PopChill — PopChill generates an online marketplace for second-hand trade, enabling users to share their fashion styles and sell idle items.
WASEDA University Ventures (WUV) is a venture capital firm specialising in founding investments by creating new start-up companies that make use of academia and are based on "the practical application of scholarship". Our mission is to be a capitalist that implements academic knowledge and
Show more...Investment focus
- Industry: Medical, Biotechnology, Information Technology
- Stage:Seed, Series A, Convertible Note
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 13
- Round size: Seed $1.2M–$38M; Series A $1.3M–$14M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Neubond — Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous assistance and therapy during daily activities, integrating rehabilitation into the patient's daily life regardless of their motor capabilities. Neubond's solutions are designed to be intuitive and effective, aiming to improve thequality of life for individuals undergoing rehabilitation.
- Pestalozzi Technology — Pestalozzi Technology is a development and provision of educational products in the fields of physical education and club activities.
- Gel-Coat Biomaterials — Gel-Coat Biomaterials is a biotechnology company that develops innovative bio-based materials and new medical technologies.
Sosei CVC is support the creation and growth of life science companies.
Show more...Investment focus
- Industry: Biotechnology, Medical, Pharmaceutical
- Stage:Series A, Series B
- Geography: Japan
Investor stats
- Total investments: 7
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Junten Bio — JUNTEN BIO is a company is to develop new technologies in the field of regenerative medicine.
- Chromocenter — Chromocenter is a next generation biopharmaceuticals Manufacturing company. It uses technologies such as artificial chromosome vectors, mainly for drug discovery such as medical pharmaceuticals
- Noile-Immune Biotech — Neurymune Biotech Co., Ltd. is a national cancer research center specializing in the development of cancer immunotherapies based on CAR-T cell therapy and a venture company from Yamaguchi University. They aim to be a leading company responsible for the next generation in the field of cancer immunotherapy.
Leave a Nest thrives to achieve global happiness by enhancing everyday life through science and education for future generation.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Corporate Round, Series B
- Geography: Japan, Singapore, Malaysia
Investor stats
- Total investments: 41
- Round size: Seed $276k–$3.4M; Series B $3.6M–$4.7M; Corporate Round $36k–$2.2M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- MUU — Welcome to Muu!! We develop animal-free dairy products that taste just like dairy from cows.
- Tenchijin — Tenchijin is optimiz human civilization using space big data.
- Terra Labo — Terra Labo conducts research and development on long-range unmanned aerial vehicles.
euglena Co., Ltd. engages in the research, development, production, and sale of microalgae with a focus on euglena. The company also manufactures and sells foods and cosmetics using euglena. It offers green juices, cookie bars, beverages, dietary supplements, and raw materials, as well as contract manufacturing/processing services; and skincare products.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Food and Beverage
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Japan, United States
Investor stats
- Total investments: 10
- Round size: Seed $527k–$3.7M; Series A $2.2M–$5.6M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- KAICO — KAICO is a pharmaceuticals, diagnostic drugs production company.
- Misaky Tokyo — Marine plant-based, handmade Japanese sweets. These crystal treats are individually handcrafted, the perfect gift idea! Vegan, gluten-free, and additive-free confectionery, with stunning flavors such as Yuzu, Matcha, and Rose. Supporting artisans in their craft. Japanese luxury sweets with a surprise inside.
- Minimal - Bean to Bar Chocolate — Minimal - Bean to Bar Chocolate sells cacao beans and handmade chocolate. Their product line includes chocolate rare cheesecake, cacao tours, chocolate bars, sweets, chocolate sandwich cookies, and sweets. Their products serve consumers.
New Energy and Industrial Technology Development Organization (NEDO) was established as a governmental organization in 1980 to promote the development and introduction of new energy technologies. Research and development of industrial technology was later added, and today NEDO is active in a wide variety of areas as one of the largest publicresearch and development management organizations in Japan.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Grant, Series A, Seed
- Geography: Japan, United States
Investor stats
- Total investments: 39
- Round size: Seed $885k–$991k; Grant $1.7M–$26M; Series A $800k–$4.7M
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- BiPSEE — BiPSEE is a medical XR company that provides treatment support for children for the purpose of nurturing a sense of self-efficacy. They also deploy AR and VR animation with one button dentistry and medicine, whether outpatient or hospitalized in various situations your child's anxiety and pain relieve. It aims to reduce anxiety and pain inchildren in a wide range of medical fields such as dentistry, pediatrics, and dermatology.BiPSEE is abs ed in Tokyo, Japan.
- Quixotiks — Quixotiks develops research-driven AI systems utilizing cognitive neuropsychology algorithms to simulate expert communication styles. The company provides automated dialogue integration and localized large language model consulting to assist healthcare, welfare, and corporate sectors.
- Asist — Asist is a startup specializing in data-driven scientific solutions, supporting data analysis and research optimization.
STRIVE focuses on investing in early-stage (Seed to Series A) internet and mobile companies. It seeks out companies in Japan, Southeast Asia, and India with top-notch management teams and strong market potential. It is not tied to strategic investments for GREE Inc. and leverages its pan-Asia expertise for guiding its portfolio in an engaged,hands-on role.
Show more...Investment focus
- Industry: Software, SaaS, Internet
- Stage:Seed, Series A, Series B
- Geography: Japan, India, Indonesia
Investor stats
- Total investments: 151
- Round size: Seed $740k–$6.5M; Series A $1.2M–$43M; Series B $3.3M–$37M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $10B in 2019
Portfolio highlights
- ASUENE — Asuene involves in clean power retail business, retail SaaS business, etc.
- Recompound — Recompound is a financial services startup that acts as a personal investment advisor for individuals to grow their stock market portfolios.
- Testsigma — Powerful cloud-based test automation platform that lets you automate tests for web, mobile, desktop apps, and APIs in minutes. Sign up now!
Higegin Capital is a venture capital firm.
Show more...Investment focus
- Industry: Medical, Biotechnology, Software
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Japan
Investor stats
- Total investments: 27
- Round size: Series A $1.2M–$9.1M; Series B $3.8M–$17M; Venture - Series Unknown $279k–$13M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — raised $9.2M in 2020
Portfolio highlights
- Molmir — Molmir is a biotech company that conducts research and develops treatments for intractable diseases based on sensing technology.
- EUV Photon — EUV Photon is an irradiation services company that conducts processing, evaluation, and measurement of materials for EUV lights.
- Restore Vision — Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.
Chugin Capital Partner is a venture capital firm that invests in startups and business succession.
Show more...Investment focus
- Industry: Manufacturing, Software, Information Technology
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Japan
Investor stats
- Total investments: 29
- Round size: Seed $246k–$7.1M; Series A $1.2M–$4M; Venture - Series Unknown $2.9M–$3M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- KG Motors — KG Motors is an automotive firm that manufactures electric vehicles that can be moved comfortably and safely by one person.
- Waku — Waku is a manufacturing company that specializes in the research and development of organic fertilizers for the agriculture industry.
- xCARE — xCARE specializes in the development and commercialization phases of the pharmaceutical and medical device industries.
Biotech Investor funding in Japan at a glance
Stats across 679 deals from 720 investors.
Access all 720 investors in Japan Biotech startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech Investors in Japan investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 720 investors investing in Japan Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!